Catheter-associated urinary tract infection (CAUTI) is one of the most common healthcare-associated infections and remains a major cause of morbidity, catheter blockage, and repeated device replacement during long-term catheterization. This narrative review examines the interfacial processes that contribute to urinary catheter failure, including protein adsorption, microbial adhesion, biofilm formation, encrustation, and swarming-associated blockage, and evaluates how zwitterionic surface coatings may address these challenges. Drawing primarily on urinary catheter-specific studies, together with adjacent zwitterionic biomaterials literature where relevant to catheter design, this review synthesizes current coating strategies with emphasis on protein repellence, lubrication, biocompatibility, multifunctionalization, interface-specific design requirements, architectural trade-offs between hydrogel-like and brush-like coatings, and approaches to improve coating durability. The review also considers translation, including interim human evidence for zwitterion-treated urinary catheters, while recognizing that these data remain conference-reported and product-specific. Overall, zwitterionic coatings should be viewed not as a single antifouling solution, but as a versatile biomaterials platform for engineering multifunctional, durable, and clinically translatable urinary catheters. However, their long-term stability, resistance to complex biofilm and encrustation processes, and clinical efficacy require further validation. To define these remaining validation needs, the review compares PC-, SB-, and CB-based systems, stratifies evidence by model and duration, reports quantitative coating data where available, and identifies validation requirements across the product lifecycle.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: